Cytokines: As useful prognostic markers in lymphoma cases

Medical Journal Armed Forces India

Volumn 60, Issue 1, 2004, Pages 45-49

  Chopra, G S ^a   Chitalkar, P G ^b   Jaiprakash, M P ^c  

^a ARMY HOSPITAL   (India)

^b Department of Pathology Command Hospital Southern Command   (India)

^c DGAFMS   (India)

Author keywords

Cytokines; IL 2R; IL 6; Lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER CLASSIFICATION; CANCER GRADING; CANCER REGRESSION; CARCINOGENESIS; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PROGNOSIS; RELIABILITY; SEX RATIO;

EID: 0942298754     PISSN: 03771237     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0377-1237(04)80158-8     Document Type: Article

References (15)

1. Macon WR. Cytokine expression in malignant lymphomas. Hum Pathol 1993;24:1039-41.
2. Skarin AT, Dorfman DM. Non-Hodgkins Lymphomas: Current classification and management. Cancer J Cin 1997;47:351-72.
3. Balkwill FR, Burke F. Immunol Today 1989;10:299-304.
4. Su Minmg HSU, Waldron JW, Hsu P et al. Cytokines in malignant lymphomas. Hum Pathol 1993;24:1040-56.
5. Hansson M. Growth and differentiation factors for B and T cell. Leuk Res 1990;14:705-10.
6. Enblad G, Sundstrom C, Gronowitz S et al. Serum levels of IL-2 receptor in patients with Hodgkins disease with special reference to age and prognosis. Ann-Oncol 1995;6:65-70.
7. Kurzrock R, Redman J, Cabanillas F et al. Serum IL-6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkins disease and with B symptoms. Cancer Res 1993;53:2118-22.
8. Pul CH, Hip S, Shulahifiah et al. Serum IL-2 receptor levels in childhood acute lymphoblastic leukaemia. Blood 1988;71:1135-7.
9. Jeffery L, Timothy M, Greiner C et al. Hodgkins disease. Cancer 1995;75:357-69.
10. Gorschluter M, Bohlen H, Hasenclever D et al. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease. Ann Oncol 1995;6:477-82.
11. Pui CH, IpP SH, Kung P et al. High serum IL-2 receptor levels are related to advance disease and a poor outcome in childhood Non-Hodgkin's lymphoma. Blood 1987;70:624-8.
12. Pui CH, Hudson M, Luo X et al. Serum IL-2 receptor levels in Hodgkin's disease and other solid tumours of childhood. Leukaemia 1993;7:1242-4.
13. Jucher M, Abb H, Liw et al. Expression of IL-2 and IL-6 in Hodgkins disease. Blood 1991;77:2413-8.
14. Freemean GJ, Freedman AS, Rabinowe SN et al. IL-6 gene expression in normal and neoplastic B cells. J Clin Invest 1998;83:1512-8.
15. Rieckman P, Alessandro F, Nordon RP et al. IL-6 and tumour necrosis factor X , autocrine and paracrine cytokines involved in B cell functions. J Immunol 1991;146:3462-8.